Nexagon®

DRUG3 trials

Sponsors

OcuNexus Therapeutics, Inc.

Conditions

Diabetic Foot UlcerPersistent Epithelial DefectVenous Ulcer

Phase 1

The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers

TerminatedNCT00820703

OcuNexus Therapeutics, Inc.Diabetic Foot Ulcer

Start: 2009-04-30End: 2009-12-31Target: 24Updated: 2010-08-31

Phase 2

A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)

CompletedNCT00820196

OcuNexus Therapeutics, Inc.Venous Ulcer

Start: 2009-03-31End: 2010-05-31Updated: 2012-09-18

A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects

WithdrawnNCT00821561

OcuNexus Therapeutics, Inc.Persistent Epithelial Defect

Start: 2009-03-31End: 2010-03-31Target: 90Updated: 2010-02-26